BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 14675586)

  • 21. How to protect from contrast media-induced nephropathy?
    Scheller B
    Clin Res Cardiol; 2007 Mar; 96(3):125-9. PubMed ID: 17294353
    [No Abstract]   [Full Text] [Related]  

  • 22. Radiocontrast-induced acute renal failure.
    Weisbord SD; Palevsky PM
    J Intensive Care Med; 2005; 20(2):63-75. PubMed ID: 15855219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
    Ma WQ; Zhao Y; Wang Y; Han XQ; Zhu Y; Liu NF
    Int Urol Nephrol; 2018 Jun; 50(6):1085-1095. PubMed ID: 29404930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between serum creatinine, volume status, N-acetylcysteine, and contrast-induced nephropathy.
    Toprak O
    Ren Fail; 2006; 28(3):265-6. PubMed ID: 16703801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
    Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
    Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A drug to prevent renal failure?
    Kellum JA
    Lancet; 2003 Aug; 362(9384):589-90. PubMed ID: 12944054
    [No Abstract]   [Full Text] [Related]  

  • 27. Q: Should N-acetylcysteine be used routinely to prevent contrast-induced acute kidney injury?
    Sivalingam SK; Hariharan MV; Braden GL; Freda BJ
    Cleve Clin J Med; 2012 Nov; 79(11):746-9. PubMed ID: 23125323
    [No Abstract]   [Full Text] [Related]  

  • 28. Protection from contrast-induced nephropathy: is the answer in?
    Dean LS
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):342-3. PubMed ID: 12594699
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of contrast nephropathy in critically ill patients using acetylcysteine and theophylline.
    Mueller C
    Int J Artif Organs; 2004 Dec; 27(12):1066-9. PubMed ID: 15645617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
    Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
    Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lessons learned from the PRESERVE trial.
    Partovi S; Trischman T; Kang PS
    Br J Radiol; 2018 Jul; 91(1087):20180092. PubMed ID: 29770709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
    Boccalandro F; Amhad M; Smalling RW; Sdringola S
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
    Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
    G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of N-acetylcysteine on the incidence of contrast-induced kidney injury: A systematic review and trial sequential analysis.
    Wang N; Qian P; Kumar S; Yan TD; Phan K
    Int J Cardiol; 2016 Apr; 209():319-27. PubMed ID: 26922293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis.
    Liu R; Nair D; Ix J; Moore DH; Bent S
    J Gen Intern Med; 2005 Feb; 20(2):193-200. PubMed ID: 15836554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.
    Zagler A; Azadpour M; Mercado C; Hennekens CH
    Am Heart J; 2006 Jan; 151(1):140-5. PubMed ID: 16368307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of bilirubin for the prevention of contrast-induced nephropathy.
    Halacli B; Ecder T
    Med Hypotheses; 2009 Feb; 72(2):232-3. PubMed ID: 18945551
    [No Abstract]   [Full Text] [Related]  

  • 38. Multimodality prevention of contrast-induced acute kidney injury.
    McCullough PA
    Am J Kidney Dis; 2008 Feb; 51(2):169-72. PubMed ID: 18215694
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic Management of Contrast-Induced Acute Kidney Injury in High-Risk Patients.
    Nahar D
    Nephrol Nurs J; 2017; 44(3):244-249. PubMed ID: 29165956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.